1 |
Anastasi E, Marchei GG (2010). HE4: a new potential early biomarker for the recurrence of ovarian cancer. Tumor Biol, 31, 113-9.
DOI
|
2 |
Berek SJ, Natarajan S (2007). Ovarian and fallopian tube cancer. In: Berek JS, editor.
|
3 |
Berek& Novak's gynecology. 14th ed. Philadelphia: Lippincott Williams& Wilkins, 1457-547.
|
4 |
Drapkin R, von Horsten HH, Lin Y, et al (2005). Human epididymis protein 4 (HE4) is a secreted glycoprotein that is overexpressed by serous and endometrioid ovarian carcinomas. Cancer Res, 65, 2162-9
DOI
|
5 |
Drapkin R, von Horsten HH, Lin Yet al (2005). Human epididymis protein 4 (HE4) is a secreted glycoprotein that is overexpressed by serous and endometrioid ovarian carcinomas. Cancer Res, 65, 2162-9
DOI
|
6 |
Govindan R,Devita A, Hellman B et al (2012). Principles and Practice of Oncology. 3 rd edition, 1586.
|
7 |
Imsamran W, Chaiwerawattana A, Wiangnon S, et al (2015). Cancer in Thailand, 3, 55.
|
8 |
Li J, Dowdy S, Tipton T et al (2009). HE4 as a biomarker for ovarian and endometrial cancer management. Expert Rev Mol Diagn, 9, 555-66.
DOI
|
9 |
Moore RG, Brown AK (2008). The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass. Gynecooocol, 2, 402-8.
|
10 |
Narakorn C (2011). Epithelial ovarian cancer. In:Srisomboon J , Wilailak S,Narakorn C et al, editor, Gynecologic oncology. Bangkok, Pimdee, 199-243.
|
11 |
Plotti F, Capriglione S (2012). Does HE4 have a role as biomarker in the recurrence of ovarian cancer. Int Society Oncol Biomarkers, 33, 2117-23
|
12 |
Trudel D (2010). Human epididymis protein 4 (HE4) and ovarian cancer prognosis. Int Society Oncol Biomarkers, 31, 113-119
|
13 |
United States Cancer Statistics: 1999-2013 (2016). Incidence and Mortality Web-based Report. Atlanta (GA): Department of Health And Human Services, Centers for Disease Control and Prevention, and National Cancer Institute.
|
14 |
Wilailak S, Khuhaprema T, Srivatanakul P, et al (2009). Epidemiologic report of gynecologic cancer in Thailand. J Gynecol Oncol, 20, 81-3.
DOI
|